$UNH has announced its Q4 2024 earnings, with EPS at $6.81, beating estimates by $0.07, while revenue of $100.81B fell short by $927.68M (6.76% Y/Y). Highlights include a medical care ratio of 86.5%, which indicates challenges, particularly from unexpected expenses and slower growth in certain sectors. Future growth hinges on their strong Medicare Advantage retention and expansion in Optum Health. Risks also lie with pricing regulations and previous reimbursement trends. Check the details at http://valueverge.com/UNH.
